ADHD, Predominantly Hyperactive - Impulsive(ADHD)NCT07069621

Triple P forADHD Children's Mothers, Education of Behavioral Problems, and Change in Mothers' Attitude

A study testing Triple p level parenting program in people with ADHD, Predominantly Hyperactive - Impulsive and Behavior Problems, Child, run by Palestine Polytechnic University at 1 site in Palestinian Territories.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The goal of this clinical trial is to investigate whether the Triple P program will reduce behavioral problems for ADHD children, improve mothers' sense of competency, and improve their attitudes The main questions it aims to answer are: 1 . Read more about this study

Who is it for?: Ages 6 to 12 years
Conditions the study is for: ADHD, Predominantly Hyperactive - Impulsive, Behavior Problems, Child, ADHD - Attention Deficit Disorder With Hyperactivity
What is being tested?: Triple p level parenting program
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 67 participants
Where: 1 sitePalestinian Territories
Study dates: 25 Jul 2023to 30 Aug 2024
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 6 to 12 years
All sexes
No healthy volunteers
Child

The inclusion criteria:

having a child aged 6 - 13 years with an ADHD diagnosis
attending a child mental health clinic
No participation with another professional agency to receive parental support for mothers.

The exclusion criterion :

having a child with ADHD combined with neurological disorders
known medical conditions, severe aggression, intellectual disability, psychosis, and bipolar disorder.
children with ADHD older than 12 or younger than 6 years

Trial locations and contacts

1 site in 1 country.

Palestinian Territories1 site

Child Mental Health Clinic
Hebron

Other trials in Palestinian Territories

About this study

Official title: Positive Parenting Program for Attention Deficit Hyperactivity Disorder: Maternal Perspective Shifts and Child Behavior Problems Reduction in a Clinical Trial

The goal of this clinical trial is to investigate whether the Triple P program will reduce behavioral problems for ADHD children, improve mothers' sense of competency, and improve their attitudes

The main questions it aims to answer are:

1 . What is the feasibility and cultural acceptability of implementing the Triple P program within the Palestinian context? 2. Does the Triple P program promote positive attitudes towards managing ADHD among mothers in Palestine? 3. How does the Triple P program affect the maternal sense of competency among mothers in Palestine? 4. Does the Triple P program delivery affect reducing children's ADHD behavioural symptoms?

Participants :

took the triple p strategies, and the control will not Outcome measures will be evaluated pre- and post-intervention

Read the detailed description

Mothers of children with ADHD are included; children with other mental health disorders or combined types of autism are excluded. The sample was taken from mental health clinics with children diagnosed with ADHD, aged 6-12 years old.

Conditions: ADHD, Predominantly Hyperactive - Impulsive, Behavior Problems, Child, ADHD - Attention Deficit Disorder With Hyperactivity, Healthy Adult Females, Competence, Positive Parenting
Being tested: Triple p level parenting program
Keywords: sense of competency,mothers,ADHD,Behavioral problems, child, parenting attitudes, triple p
Medical subject headings: Attention Deficit Disorder with Hyperactivity, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Triple p level parenting programBehavioural
An evidence-based program with self-agency strategies enhances trust and confidence in managing children's ADHD behaviors

Study groups in NCT07069621
Study group	Role	What they receive
Mothers of children with ADHD and with children with ADHD aged 6-12 years	Experimental	Had the Triple P sessions Receives: Behavioral: Triple p level parenting program
control	No intervention	Did not receive triple p

What is being measured

The primary outcome is the main question the study is designed to answer.

SDQ: Strengths and Difficulties Questionnaire SDQ
The Strengths and Difficulties Questionnaire (SDQ) is a validated behavioral screening tool that assesses emotional and behavioral difficulties in children through 25 items grouped into five subscales: Emotional Symptoms, Conduct Problems, Hyperactivity/Inattention, Peer Relationship Problems, and Prosocial Behavior. Each subscale includes 5 items scored from 0 to 2, resulting in subscale scores ranging from 0 to 10. Higher scores on the first four subscales indicate greater difficulties, while higher scores on the Prosocial Behavior subscale reflect better social functioning. A Total Difficulties Score (the lowest is 0 and the highest is 40) is calculated by summing the four difficulties subscales, with higher scores indicating more behavioral problems. Scores are reported as mean ± standard deviation, with higher total or subscale scores indicating worse outcomes for difficulties and better outcomes for prosocial behavior (Goodman, 1997; Stone et al., 2010)
Measured: Pre (Baseline) intervention and Post (12 months)

Secondary outcomes (2)

Parenting Scale
The Parenting Scale - Short Version is a brief 7-item parent-report tool designed to assess dysfunctional parenting discipline styles. It measures two core constructs:
Laxness (4 items): Reflects permissive discipline and inconsistent enforcement of rules.
Overreactivity (3 items): Captures harsh, irritable, or angry responses to child misbehavior.
Each item is rated on a 7-point Likert-type scale, ranging from 1 (effective discipline) to 7 (ineffective discipline). Scores are computed as follows:
Subscale Scores:
Laxness score: Mean of 4 items (range: 1.0-7.0) higher scores mean worse it should not exceed 4
Over reactivity score: Mean of 3 items (range: 1.0-7.0) higher scores are worse , cutoff is 4
Total Score: Mean of all 7 items (range: 1.0-7.0)
Measured: "Pre (Baseline)"intervention and "Post (12 months)")
PSOC: Parenting Sense of Competence PSOC Scale
The Parenting Sense of Competence (PSOC) scale (Gibaud-Wallston \& Wandersman, 1978) is a 17-item self-report instrument assessing parents' perceived competence in their parenting role. Each item is rated on a 6-point Likert scale (1 = strongly disagree to 6 = strongly agree) . Possible Score Range: 16 to 96
Interpretation of Range:
High Total Score (e.g., 75+): Generally indicates a positive, adaptive parenting self-concept.
Low Total Score (e.g., below 50): Indicates significant parenting distress and is a red flag for needed support.
- with higher scores indicating greater parenting efficacy and satisfaction"
Measured: "Pre (Baseline)"intervention and "Post (12 months)")

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

25 Jul 202330 Aug 2024

First posted17 Jul 2025
Study start25 Jul 2023
Primary completion30 Aug 2024
Study completion30 Aug 2024

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for ADHD, Predominantly Hyperactive - ImpulsiveStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Supportive care
Allocation: Randomised
Intervention model: Parallel groups
Model description: One group received the Triple P program
Masking: Double blind
Who is masked: Participant, Investigator
Enrolment: 67 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07069621
Sponsor's protocol ID: R-2024/A/131/N
Acronym: (ADHD)
Status last verified: Jan 2026
First submitted: 21 Jun 2025
Last updated: 29 Jan 2026
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: Yes: the whole process sesign prtocol ,data collection can be siscussed

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

RecruitingPhase 2
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Neurodevelopmental Disorders, Autism
Recruiting
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
ADHD, ADHD - Combined Type
Recruiting
NeuroTrainer Cognitive Training For Academic Focus
ADHD - Combined Type, ADHD Predominantly Inattentive Type
Not yet recruiting
The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.
Attention Deficit Disorder, Attention Deficit Disorder (ADD)

All ADHD, Predominantly Hyperactive - Impulsive trials

Study at a glance

From the registry record, last updated by the sponsor on 29 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Positive Parenting Program for Attention Deficit Hyperactivity Disorder: Maternal Perspective Shifts and Child Behavior Problems Reduction in a Clinical Trial
ClinicalTrials.gov ID: NCT07069621
Acronym / sponsor ID: (ADHD) / R-2024/A/131/N
Conditions: ADHD, Predominantly Hyperactive - Impulsive, Behavior Problems, Child, ADHD - Attention Deficit Disorder With Hyperactivity, Healthy Adult Females, Competence, Positive Parenting
Keywords: sense of competency,mothers,ADHD,Behavioral problems, child, parenting attitudes, triple p
Study type: Interventional
Recruitment status: Completed
Enrolment: 67 participants (actual)
Lead sponsor: Palestine Polytechnic UniversityUniversity, hospital or other
Study start: 25 Jul 2023 (actual)
Primary completion: 30 Aug 2024 (actual)
Study completion: 30 Aug 2024 (actual)
First posted: 17 Jul 2025 (actual)
Results: Posted 29 Jan 2026

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

The goal of this clinical trial is to investigate whether the Triple P program will reduce behavioral problems for ADHD children, improve mothers' sense of competency, and improve their attitudes

The main questions it aims to answer are:

Participants :

took the triple p strategies, and the control will not Outcome measures will be evaluated pre- and post-intervention

Detailed description

Study design

Primary purpose: Supportive care
Allocation: Randomised
Intervention model: Parallel groups
Masking: Double blind (participant, investigator)
Number of arms: 2
Model description: One group received the Triple P program

Arm	Type	Receives
Mothers of children with ADHD and with children with ADHD aged 6-12 years	Experimental	Behavioral: Triple p level parenting programHad the Triple P sessions
control	No intervention	–Did not receive triple p

Who may qualify

Ages: 6 to 12 years
Sex: All
Healthy volunteers: Not accepted
Age groups: Child

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Triple p level parenting programAn evidence-based program with self-agency strategies enhances trust and confidence in managing children's ADHD behaviors	Behavioural	Mothers of children with ADHD and with children with ADHD aged 6-12 years

Primary outcome

SDQ: Strengths and Difficulties Questionnaire SDQ
Time frame: Pre (Baseline) intervention and Post (12 months)
The Strengths and Difficulties Questionnaire (SDQ) is a validated behavioral screening tool that assesses emotional and behavioral difficulties in children through 25 items grouped into five subscales: Emotional Symptoms, Conduct Problems, Hyperactivity/Inattention, Peer Relationship Problems, and Prosocial Behavior. Each subscale includes 5 items scored from 0 to 2, resulting in subscale scores ranging from 0 to 10. Higher scores on the first four subscales indicate greater difficulties, while higher scores on the Prosocial Behavior subscale reflect better social functioning. A Total Difficulties Score (the lowest is 0 and the highest is 40) is calculated by summing the four difficulties subscales, with higher scores indicating more behavioral problems. Scores are reported as mean ± standard deviation, with higher total or subscale scores indicating worse outcomes for difficulties and better outcomes for prosocial behavior (Goodman, 1997; Stone et al., 2010)

2 secondary outcomes

Parenting Scale
Time frame: "Pre (Baseline)"intervention and "Post (12 months)")
PSOC: Parenting Sense of Competence PSOC Scale
Time frame: "Pre (Baseline)"intervention and "Post (12 months)")

Results and safety

Results posted to the registry on 29 Jan 2026, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
INTERVENTION	33	33
Control	31	31

Primary outcome: SDQ: Strengths and Difficulties Questionnaire SDQ

Time frame: Pre (Baseline) intervention and Post (12 months). Mean (Standard Deviation). Unit: score on a scale

Measure	Intervention n = 33	Control n = 31
hyperactivity pre	8.22 (1.98)	7.71 (2.04)
hyperactivity post	6.78 (2.70)	7.97 (2.01)
Prosocial Pre	7.47 (2.29)	6.42 (2.81)
prosocial Post	7.72 (2.20)	6.19 (2.57)
SDQ-Peer Problems Pre	4.38 (1.88)	3.84 (1.51)
SDQ-Peer Problems (Post)	3.97 (1.71)	3.90 (1.76)
SDQ-Total Score Pre	19.78 (5.56)	21.32 (6.09)
SDQ-Total Score Post	19.28 (6.71)	21.52 (5.54)

Population analysed: mothers of ADHD children

2 secondary outcomes are reported in the full results.

Adverse events

Time frame: 13 months, adverse events monitored but not found. Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Intervention	0 of 33 (0%)	0 of 33 (0%)	0 of 33
Control	0 of 31 (0%)	0 of 31 (0%)	0 of 31

Limitations and caveats (from the sponsor): First, the study used a pre-post design with no long-term follow-up, limiting insight into sustained effects. Second, the sample size was modest, affecting generalizability. Third, intervention delivery by a single researcher may have introduced social desirability bias. Lastly, data collection occurred during the Gaza conflict and lockdowns. Early termination leading to small numbers of subjects analyzed; Technical problems with measurement leading to unreliable or uninterpretable data.

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2026.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: Yes. the whole process sesign prtocol ,data collection can be siscussed

Related trials for ADHD, Predominantly Hyperactive - Impulsive

RecruitingPhase 2
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Neurodevelopmental Disorders, Autism
Recruiting
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
ADHD, ADHD - Combined Type
Recruiting
NeuroTrainer Cognitive Training For Academic Focus
ADHD - Combined Type, ADHD Predominantly Inattentive Type
Not yet recruiting
The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.
Attention Deficit Disorder, Attention Deficit Disorder (ADD)

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Nadia A Amro, phd principal investigator

AAUP

Nadia A Amro, phd principal investigator

Palestine Polytechnic University

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Palestinian Territories. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 29 Jan 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SDQ: Strengths and Difficulties Questionnaire SDQ (time frame: Pre (Baseline) intervention and Post (12 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07069621.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.